Biosimilar Advisory Committees Getting Smoother, Even As Worries Stay The Same
Executive Summary
US FDA advisors overwhelming endorse Hospira's biosimilar referencing Amgen's Epogen, but still wanted broader immunogenicity data and postmarketing surveillance.